In the NOBORI Biolimus-Eluting Versus XIENCE V/PROMUS Everolimus-Eluting Stent Trial ( NEXT ) , a formal OCT substudy investigated @ patients ( @ EES-treated lesions in @ patients and @ BES-treated lesions in @ patients ) with @-@ months follow-up imaging at @ centers .